Paper Details

  1. Home
  2. Paper Details

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Author: DickinsonHeather O, KitchenerHenry C, Winter-RoachBrett A

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Epithelial ovarian cancer is diagnosed in 4500 women in the UK each year, with 1700 deaths. Only 10-15% of cases are caught early, when there's a better chance of cure. Early-stage treatment involves surgery to remove the cancer, often followed by chemotherapy. Large studies show that chemotherapy after surgery improves survival rates, but more research is needed to figure out the best way to use chemotherapy for different patients.
Paper Details　
Original Abstract of the Article :
Epithelial ovarian cancer is diagnosed in 4500 women in the UK each year of whom 1700 will ultimately die of their disease. Ten to fifteen percent of all cases are diagnosed early when there is still a good possibility for cure. The treatment of early stage disease involves surgery to remove disease...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD004706.pub3

データ提供：米国国立医学図書館（NLM）

Adjuvant Chemotherapy for Early Stage Ovarian Cancer

This research delves into the complex world of ovarian cancer, a disease that affects many women. The focus is on early stage ovarian cancer, a condition where there's a greater possibility for cure. The study examines the role of adjuvant chemotherapy, a treatment given after surgery, in improving survival rates for patients with early stage ovarian cancer. This research is like a camel caravan searching for a hidden oasis, seeking to optimize treatment strategies for a challenging disease. The study reviewed existing clinical trials and found that adjuvant platinum-based chemotherapy has been associated with improved overall survival. However, the study highlights the need for further research to understand the precise role of this treatment in various patient subgroups.

Survival Advantage: Adjuvant Chemotherapy for Ovarian Cancer

The study's findings suggest that adjuvant chemotherapy can improve survival rates for patients with early stage ovarian cancer. This research is like a camel caravan discovering a new source of water, offering a potential path to improved outcomes for patients. While adjuvant chemotherapy has shown promise, the optimal approach for different patient groups remains an area of active investigation.

Navigating Ovarian Cancer Treatment: A Personalized Approach

Early detection and timely treatment are crucial for improving survival rates in ovarian cancer. This research, like a camel caravan following ancient trade routes, emphasizes the importance of evidence-based approaches in cancer care. Remember, just as a camel adapts to different environments, each patient's journey with ovarian cancer is unique. Working closely with your doctor to develop a personalized treatment plan that addresses your specific needs is essential for optimizing care.

Dr. Camel's Conclusion

This study, like a camel caravan searching for a lost oasis, has illuminated the potential benefits of adjuvant chemotherapy for early stage ovarian cancer. While the research highlights the importance of this treatment, it also underscores the need for further investigation to ensure personalized and effective care for each patient. Remember, just as a camel adapts to its surroundings, navigating the challenges of ovarian cancer requires a collaborative approach between patients and medical professionals.

Date :
  1. Date Completed 2009-08-14
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

19588360

DOI: Digital Object Identifier

10.1002/14651858.CD004706.pub3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.